Feature | June 13, 2019

Most Popular Cardiology Technology Content in May 2019

Several electrophysiology advances presented as late-breaking studies at the 2019 Heart Rhythm Society (HRS) annual meeting in May made the top 25 list this month. Among these was the Parasym Salustim device ear clip that stimulates the vagus nerve, which was found to reduced AF burden compared with a sham procedure in the TREAT AF trial. Another innovation was first in human data on Medtronic's Extravascular ICD, which is its version of a subcutaneous ICD that does not require placing venous leads

Several electrophysiology advances presented as late-breaking studies at the 2019 Heart Rhythm Society (HRS) annual meeting in May made the top 25 list this month. Among these was the Parasym Salustim device ear clip that stimulates the vagus nerve, which was found to reduced AF burden compared with a sham procedure in the TREAT AF trial. Another innovation was first-in-human data presented on Medtronic's Extravascular ICD, which is its version of a subcutaneous ICD that does not require venous or intracardiac leads.

June 12, 2019 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) magazine website from the month of May 2019. This is based on the website’s 261,227 pageviews for the month:

1. Noninvasive Ear-Clip Nerve Stimulation Suppresses Atrial Fibrillation

2. Heart Rhythm Society 2019 Late-Breaking Clinical Trials

3. Taking The Heart Team Staffing Business Seriously

4. The Basics of the Pediatric Tachycardia for Pediatric Advanced Life Support

5. First-in-human Study Positive of Medtronic Extravascular ICD System

6. 4 Key Takeaways From the 2019 Heart Rhythm Society Meeting

7. Edwards Announces Research Milestones for Pascal Transcatheter Mitral Valve Program

8. EuroPCR 2019 Hot Line Late-Breaking Interventional Cardiology Trials

9. VIDEO: Overview of the Watchman Left Atrial Appendage Occluder and its Implantation Procedure

10. SCAI Releases New Consensus Document on Classification Stages of Cardiogenic Shock

11. Innovations in Cardiology at Henry Ford Hospital

12. Electromechanical Wave Imaging Can Correctly Localize Cardiac Arrhythmias

13. Mick Jagger Recovering After TAVR Procedure

14. VIDEO: Developing New Cath Lab Technologies With Real-time Collaboration Between Industry, Doctors

15. Boston Scientific Receives FDA Approval for Lotus Edge Aortic Valve System

16. How Will Artificial Intelligence Impact Healthcare?

17. Open Heart Surgery Outperforms Stents in Patients With Multivessel Disease

18. Varian Acquires CyberHeart Cardiac Radio-ablation Technology

19. Philips and Medtronic Collaborate on Image-guided Atrial Fibrillation Treatment

20. FDA Clears Boston Scientific Vici Venous Stent to Treat Deep Venous Blockages

21. Late Dinner and No Breakfast Worsens Outcomes After Heart Attack

22. Rotor Ablation Fails to Beat Conventional Therapy in Persistent AFib

23. New LAMPOON Technique Reduces LVOT Obstruction in Transcatheter Mitral Valve Replacement

24. Airport Security Body Scanners Do Not Interfere With Pacemakers, ICDs

25. Reducing Economic Burden of Cardiorenal Syndrome With The Aortix Pump

 

Related Most Popular Cardiology Content:

Most Popular Cardiology Technology Content in April 2019

Most Popular Cardiology Technology Content in March 2019

Most Popular Cardiology Technology Content in February 2019

Most Popular Cardiology Technology Content in January 2019

The Most Popular Cardiology Topics in 2018

Most Popular Cardiology Technology Content in November 2018

Related Content

The BardyDx Carnation Ambulatory Monitor (CAM) is a P-wave centric wearable ambulatory cardiac patch monitoring and arrhythmia detection device. 

The BardyDx Carnation Ambulatory Monitor (CAM) is a P-wave centric wearable ambulatory cardiac patch monitoring and arrhythmia detection device. 

News | Cardiac Diagnostics | July 29, 2021
July 29, 2021 — A recent clinical study from Overlake Medical Center utilizing the Bardy Diagnostics Carnation Ambula
The FDA has cleared Angel Medical Systems' second-generation AngelMed Guardian device. The implantable cardiac device detects and warns patients if they are having an acute coronary syndrome (ACS) event, including silent heart attacks. The new, second-generation device is enhanced with ease-of-use adaptations and an updated, long life battery that could potentially double the life of the implanted device

The FDA has cleared Angel Medical Systems' second-generation AngelMed Guardian device. The implantable cardiac device detects and warns patients if they are having an acute coronary syndrome (ACS) event, including silent heart attacks. The new, second-generation device is enhanced with ease-of-use adaptations and an updated, long life battery that could potentially double the life of the implanted device

News | Cardiac Diagnostics | July 01, 2021
July 1, 2021 — The U.S. Food and Drug Administration (FDA) has cleared the Angel Medical Systems Inc.
Ophthalmic optical coherence tomography (OCT) scan view of the macula in retina with vessels. Detecting heart disease with OCT imaging of the eye.Getty Images

Ophthalmic optical coherence tomography (OCT) scan view of the macula in retina with vessels. Getty Images
 

News | Cardiac Diagnostics | March 08, 2021
March 8, 2021 — In a new study from Shiley Eye Institute at UC San Diego Health, researchers have identified a potent
Alivecor's pocket ECG system allows consumers or cardiologists to record a single lead ECG. AI algorithms can determine if their ECG is normal or abnormal and identify the arrhythmia.

Alivecor's pocket ECG system allows consumers or cardiologists to record a single lead ECG strip on a smartphone. AI algorithms can determine if their ECG is normal or abnormal and identify the arrhythmia. 

News | Cardiac Diagnostics | March 03, 2021
March 3, 2021 — AliveCor recently announced a new collaboration with AstraZeneca to research new disease management s
A study of more than 100 million Americans in 3,123 counties found a correlation between cardiac death and their level of income. Getty Images Health disparities in cardiovascular disease.

A study of more than 100 million Americans in 3,123 counties found a correlation between cardiac death and their level of income. Getty Images

News | Cardiac Diagnostics | February 02, 2021
February 2, 2021 — A new study has found in the U.S.
A new study highlights the importance of continued public education regarding the risks of cigarette smoking and the failure of dual use with vaping to reduce cardiovascular risk. Getty Images

A new study highlights the importance of continued public education regarding the risks of cigarette smoking and the failure of dual use with vaping to reduce cardiovascular risk. Getty Images

News | Cardiac Diagnostics | January 06, 2021
January 6, 2021 — Smoking traditional cigarettes in addition to using e-cigarettes results in harmful health effects
The Mesuron Inc. Avalon-H90 uses magnetometers to detect myocarditis in patients without any physical contact. It uses ventricular repolarization dynamics analysis software to look for abnormalities. The vendor said it is more specific than using ECG. It detects the multidimensional dynamics of the electrical activity caused by differences in functions of electrical action potential of normal heart tissues and abnormal ones with hypoxia.

The Mesuron Inc. Avalon-H90 uses magnetometers to detect myocarditis in patients without any physical contact. It uses ventricular repolarization dynamics analysis software to look for abnormalities. The vendor said it is more specific than using ECG. It detects the multidimensional dynamics of the electrical activity caused by differences in functions of electrical action potential of normal heart tissues and abnormal ones with hypoxia. 

News | Cardiac Diagnostics | October 06, 2020
October 6, 2020 — A new technology being developed by U.S.-based Mesuron Inc.
With the advent and optimization of nuclear scintigraphy protocols using bone-avid radiotracers, cardiac amyloidosis caused by transthyretin protein (ATTR) can now be diagnosed noninvasively without a costly tissue biopsy. The radiotracer 99mTc-pyrophosphate (99mTc-PYP) binds to deposited ATTR amyloid fibrils in the myocardium and can be visualized using planar and SPECT imaging. Amyloidosis Patient Registry  #Amyloidosis

With the advent and optimization of nuclear scintigraphy protocols using bone-avid radiotracers, cardiac amyloidosis caused by transthyretin protein (ATTR) can now be diagnosed noninvasively without a tissue biopsy. The radiotracer 99mTc-pyrophosphate (99mTc-PYP) binds to deposited ATTR amyloid fibrils in the myocardium and can be visualized using planar and SPECT imaging. This is Figure 2, showing how SPECT imaging allows the reader to distinguish between blood pool activity (ventricular cavity, etc) and myocardial activity and identify regional myocardial differences in radiotracer uptake.

News | Cardiac Diagnostics | March 05, 2020
March 5, 2020 — More than 300 patients have joined the Amyloidosis Patient Registry and it is now available to the en